INCENTIVE QIV-1/2/3 demographic data

The Indo-European Consortium for Next Generation Influenza Vaccine Innovation (INCENTIVE) is an EU Horizon H2020 project (grant ID: 874866) in collaboration with the Department of Biotechnology, Government of India (project no. BT/IN/EU-INF/16/AP/19-20/11746). One of the main goals is to advance knowledge of the underlying mechanisms of poor responsiveness to influenza vaccines. To achieve this goal, comprehensive immune profiling of responders and non-responders to a licensed quadrivalent inactivated influenza vaccine (QIV) is performed in vulnerable populations: elderly (≥60 years) (QIV1), children (3-8 years) (QIV2) and in infants (6-7 months born to mothers immunized during pregnancy) (QIV3), participating in phase IV trials in Europe and India.

The current dataset contains demographic data of the European QIV1, QIV2, and QIV3 trials only. The data is pseudonymized and contains, amongst other parameters, participant gender, age, race, and number of administered vaccine doses.